Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
05/2002
05/29/2002EP1208091A1 Benzophenones as inhibitors of reverse transcriptase
05/29/2002EP1019531A4 A method to assay enzymatic covalent bond formation and cleavage
05/29/2002CN1351635A Reactive dye compounds
05/29/2002CN1351595A Substituted polycyclic aryl and heteroacryl pyrazinones useful for selective inhibition of the coagulation cascade
05/29/2002CN1351592A Acyl derivatives which treat VL4-4 related disorders
05/29/2002CN1351497A Aminopyrimidines as sorbitol dehydrogenase inhibitors
05/29/2002CN1085663C Aromatic amino ethers as pain relieving agents
05/28/2002US6395809 Salt formation with hydrochloric, sulfuric, or phosphoric acid; automobiles, electronics
05/28/2002US6395735 An indane-like compounds which can be useful for treating psychosis and other conditions associated with modulation of a muscarinic receptor
05/28/2002US6395367 Electroconductivity
05/23/2002WO2002040457A1 Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
05/23/2002WO2002040456A1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
05/23/2002WO2001044206A9 Pyrazine based inhibitors of glycogen synthase kinase 3
05/23/2002US20020061916 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
05/23/2002US20020061890 Angiogenesis inhibiting 5-substituted-1,2,4,-thiadiazolyl derivatives
05/23/2002US20020061878 Diazacycloalkanedione derivatives
05/23/2002CA2448729A1 Piperazinyl and piperidyl substituted heterocyclic compounds
05/22/2002EP1207152A2 Pesticides
05/22/2002EP1206467A1 N-heterocyclic derivatives as nos inhibitors
05/22/2002CN1350540A Process for preparing amine platinum complexes
05/22/2002CN1350530A 酰胺衍生物 Amide derivatives
05/22/2002CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
05/22/2002CN1350512A Method of preparing surface-active alcohols and surface-active alcoholic ethers, products obtained by said method and their use
05/21/2002US6392048 Process for preparing carbocyclic or heterocyclic nitriles by vapor phase ammoxidation
05/21/2002US6392042 Polyhydroxyalkylpyrazine derivatives, their preparation and medicaments comprising them
05/21/2002US6391910 Opioid antagonist; analgesic
05/21/2002US6391877 Eating disorders; sexual disorders; antidepressants; antiepileptic agents
05/16/2002WO2002038552A1 A novel method for the preparation of piperazine and its derivatives
05/16/2002WO2001092228A3 Process for the synthesis of amine ethers from secondary amino oxides
05/16/2002WO2001079195A3 Pyridine and pyrazine derivatives as thrombin inhibitors
05/16/2002US20020058768 For use in addition polymerization of olefins
05/16/2002US20020058657 2-[1H]-quinolone and 2-[1H]-quinoxalone inhibitors of factor Xa
05/16/2002US20020058583 Stereospecific catalysts for polymerization of addition polymerizable monomers
05/15/2002EP1204648A1 N-oxyl radicals
05/15/2002EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof
05/15/2002EP1204643A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
05/15/2002EP1204429A2 Sustained release formulation of a peptide
05/15/2002EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
05/15/2002CN1349525A Di-aryl acid derivatives as PPAR receptor ligands
05/15/2002CN1349519A Glucokinase activators
05/15/2002CN1349511A Benzimidazolrone and analogues, and the use as ligand of progesterone
05/15/2002CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators
05/15/2002CN1349411A Compositions containing benzimidazolones and progestogens
05/15/2002CN1084740C Angiogensis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
05/14/2002US6388796 Electrochromism, photostability and glass plates
05/14/2002US6388127 Cyclization using dehydration agent
05/14/2002US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors
05/14/2002US6387906 Dermatophytes
05/14/2002US6387902 Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP
05/14/2002US6387547 Compound having naphthacene skeleton for use in organic electroluminescence device; produces light emission of satisfactory luminance, especially at long wavelength; improved light emitting performance lasts for long time
05/10/2002WO2002036581A1 Radiopharmaceuticals for diagnosing alzheimer's disease
05/10/2002CA2424598A1 Radiopharmaceuticals for diagnosing alzheimer's disease
05/09/2002US20020055634 Method for producing high melting point crystals of phenoxypropionic acid derivative
05/09/2002US20020055631 N-acylsulfonamide apoptosis promoters
05/09/2002US20020055522 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury.
05/08/2002EP1203762A2 Cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods
05/08/2002EP1202976A1 Pyrazinones, compositions containing such compounds
05/08/2002EP1202975A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
05/08/2002EP1202968A2 Antibacterial agents
05/08/2002EP1202738A1 Dihydropyrazine derivatives as npy antagonists
05/08/2002EP1202731A2 Method for treating chronic pain using mek inhibitors
05/08/2002EP1202729A1 Phosphate transport inhibitors
05/07/2002US6384224 For therapy and prophylaxis of psychotic disorders such as schizophrenia and other central nervous system disease
05/02/2002WO2002034728A1 4-n-acyl-δ5-2-oxopiperazines, a process for its preparation and combinatorial libraries thereof
05/02/2002WO2002034720A1 Process for preparing vinyl-substituted heterocycles
05/02/2002WO2002005822A3 Compositions containing therapeutically active components having enhanced solubility
05/02/2002WO2001090074A3 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
05/02/2002WO2001082913A3 Use of benzamide derivatives for the treatment of high ocular tension and glaucoma
05/02/2002US20020052512 Diaminopropionic acid derivatives
05/02/2002US20020051828 Mixtures which can be isolated from eugenia jambolana lamarck seeds, their preparation and the use of these mixtures and some of their constituents as medicaments
05/02/2002US20020051278 Electrochromic media for producing a preselected color and devices comprising same
05/02/2002EP1201650A2 Ionic malonitril derivatives and their uses
05/02/2002EP1200824A1 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
05/02/2002EP1200396A1 Naphthylsulfonic acids and related compounds as glucose uptake agonists
05/01/2002CN1083842C [1,2,4] triazolo [4,3-a] quinoxalinone derivs., their preparation and use
04/2002
04/30/2002US6380384 Anxiolytic agents
04/30/2002US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
04/30/2002US6380249 HIV integrase inhibitors
04/30/2002US6380235 Useful as progesterone receptor agonists and antagonists, used for contraception, in therapy of fibroids, endometriosis, breast, uterine, ovarian and prostate cancer, and post menopausal hormone replacement therapy
04/30/2002US6380223 For therapy of diseases, such as obesity, diabetes, inflammation
04/30/2002US6380197 For treating and preventing a plethora of diseases including diabetes
04/30/2002US6380186 Psychotherapeutic agents
04/30/2002US6379823 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye
04/30/2002US6379655 For protection of human skin and/or hair against the damaging effects of ultraviolet irradiation
04/30/2002CA2059787C Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient
04/25/2002WO2002032901A2 Bridged piperazine derivatives
04/25/2002WO2001097810A3 Use of therapeutic benzamide derivatives
04/25/2002US20020049323 Anxiolytic agents
04/25/2002US20020049214 Aralkyl and aralkylidene heterocyclic lactams and imides as selective agonists and antagonists of serotonin 1 (5-HT1) recepor, used in treating hypertension and all forms of depression
04/25/2002US20020049201 Sulfonamide inhibitors of aspartyl protease
04/25/2002US20020048687 Efficient light emission and excellent heat resistance
04/25/2002CA2423789A1 Bridged piperazine derivatives
04/24/2002EP1199306A1 Biarylurea derivatives
04/24/2002CN1346355A Novel inhibitors of farnesyl-protein transferase
04/24/2002CN1346350A Compound which inhibiti leukocyte adhesion mediated by VLA-4
04/24/2002CN1083448C 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (D4)
04/24/2002CN1083432C Process for preparing amine compound and its salt
04/23/2002US6376656 Disazo dyes, triazine dyes
04/23/2002US6376548 Enhanced propertied pesticides
04/23/2002US6376490 Strong n-methyl-d-asparate receptor antagonists; useful in treating strokes, ischemia, and central nervous system injuries